Entero Healthcare Solutions Ltd: Board Meeting Approves Acquisition of Five Pharmaceutical Companies and Changes in Designation

Entero Healthcare Solutions Ltd held a board meeting on May 27, 2025, approving various decisions. The company approved the audited financial results for the quarter and year ended March 31, 2025. Mr. Kevin Daftary, a Non-Executive, Non-Independent Director, will be redesignated as a Nominee Director representing Prasid Uno Family Trust. The board also appointed M/s. BNP & Associates as the Secretarial Auditor for five consecutive years. Entero Healthcare Solutions Ltd approved the execution of definitive agreements to acquire five pharmaceutical companies and to acquire 80% stake in Anand Medical Distributors, a proprietorship firm. The company also approved the allotment of 1200 equity shares to eligible employees under the Entero Employee Stock Option Plan 2023. Furthermore, the board approved the further acquisition of 16% equity shares of Peerless Biotech Private Limited from existing minority shareholders.